Postpartum HELLP Syndrome Management
The cornerstone of postpartum HELLP management is prompt delivery once maternal coagulopathy and severe hypertension are corrected, followed by aggressive blood pressure control, magnesium sulfate for seizure prophylaxis when indicated, and close monitoring for life-threatening complications—corticosteroids should NOT be used to improve maternal outcomes. 1
Immediate Post-Delivery Priorities
Blood Pressure Management
- Non-severe hypertension (BP 140-159/90-109 mmHg): Initiate oral labetalol, nifedipine, or methyldopa 1
- Severe hypertension (BP >160/>110 mmHg): Urgent treatment in monitored setting with oral agents; escalate to IV labetalol or hydralazine if needed 1
Seizure Prophylaxis
- Magnesium sulfate is mandatory for patients with HELLP syndrome and co-existing severe hypertension to prevent eclamptic seizures 1
- Dose per local/national protocols
Critical Monitoring Requirements
Laboratory surveillance:
- Platelet count (transfuse if <100×10⁹/L due to increased coagulopathy risk) 1
- Liver enzymes (AST, ALT)
- LDH, bilirubin
- Coagulation parameters (INR, aPTT)
- Renal function
Clinical vigilance for complications:
- Hepatic hemorrhage/hematoma: Perform abdominal ultrasound if patient reports abdominal, epigastric, or right shoulder pain 1
- Highest risk: Platelet count <20×10⁹/L 1
What NOT to Do
Corticosteroids should NOT be given to improve maternal outcomes in HELLP syndrome 1. This is a Level 1 evidence, strong recommendation from the 2023 EASL guidelines. While some older studies suggested benefit, the most authoritative current guidance explicitly contradicts this practice for maternal indications.
Important caveat: The guideline evidence is clear that corticosteroids don't improve maternal outcomes. However, recent research studies 2, 3 from 2019 and 2016 suggest high-dose dexamethasone may accelerate platelet recovery postpartum. This creates a clinical dilemma—follow the guideline recommendation and avoid corticosteroids for maternal benefit, as the guideline evidence is stronger and more recent than the conflicting research.
Advanced Interventions for Severe/Refractory Cases
Therapeutic Plasma Exchange (TPE)
When standard management fails and laboratory/clinical parameters worsen postpartum:
- Consider TPE for severe postpartum HELLP unresponsive to supportive care 4
- Optimal timing: Initiate within 24-48 hours post-delivery in non-responders 4
- Recent 2025 data shows significant improvements in platelet count, LDH, INR, aPTT, ALT, AST, and bilirubin 4
- Typically requires 1-3 sessions 4
Important limitation: Current guidelines note insufficient data to recommend TPE outside specialized centers with high-dependency/ICU expertise 1. However, the 2025 research 4 provides the most recent evidence supporting early TPE in severe cases.
Hepatic Failure Management
- Early referral to transplant center if signs of hepatic failure develop 1, 5
- This is non-negotiable for potential transplant candidates
Common Pitfalls to Avoid
Assuming delivery resolves everything: 20% of HELLP cases occur within 48 hours post-delivery, and some patients worsen postpartum 5
Missing hepatic complications: Don't wait for dramatic symptoms—maintain low threshold for imaging with abdominal pain
Discontinuing magnesium sulfate too early: Continue seizure prophylaxis as clinically indicated, not just during labor
Using corticosteroids for maternal benefit: Despite some older literature, current high-quality guidelines explicitly recommend against this 1
Delayed recognition of atypical HUS: If thrombotic microangiopathy persists beyond 48-72 hours postpartum, consider alternative diagnoses like pregnancy-associated atypical HUS requiring complement testing and plasma exchange 6
Multiorgan Failure Red Flags
Watch for development of:
- Sepsis
- Pulmonary edema
- Renal failure requiring dialysis
- Cerebrovascular events
- DIC
These complications occurred in 42.8% of severe HELLP patients requiring TPE 4, emphasizing the need for ICU-level monitoring in severe cases.